Clinical trial
Metyrapone as Additive Treatment in Major Depression
NCT00125554 · Universitätsklinikum Hamburg-Eppendorf, Other · Completed
Key facts
| NCT number | NCT00125554 |
|---|---|
| Title | Metyrapone as Additive Treatment in Major Depression |
| Official title | Double-Blind, Placebo Controlled Trial of Metyrapone as Augmenting Agent in the Treatment of Major Depression |
| Lead sponsor | Universitätsklinikum Hamburg-Eppendorf, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder |
| Intervention type | Drug |
| Interventions | Metyrapone |
| Enrollment | 63 |
| Start date | May 1, 1998 |
| Completion | Jul 1, 2001 |
| First posted | Aug 1, 2005 |
| Last update posted | Aug 12, 2005 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: